Raj S Dattani, MD

Raj S Dattani, MD has worked at Weatherden as a Senior Drug Development Clinician from August 2022 to present. Prior to this, they worked at Weatherden as a Drug Development Clinician from August 2020 to August 2022. Currently, they are also the Co-Founder of Sania Therapeutics starting from March 2022.

Raj S Dattani, MD pursued their education in a sequential manner. Raj S first attended Queen Mary University of London from 2010 to 2013, where they obtained their Bachelor of Science (BSc) degree in Biomedical Sciences. Following this, from 2013 to 2017, they enrolled at the University of Oxford. Here, they completed the BM BCh (Graduate Entry Medicine) program, focusing on the field of Medicine.